Clinical Software in Georgia

StrideLink Inc. is a digital health company specializing in gait monitoring and recovery analytics for orthopedic surgery patients. The platform captures continuous gait data through wearable sensors paired with a mobile app, enabling pre-operative benchmarking, real-time post-operative tracking, and structured clinical documentation throughout the recovery journey. The system supports knee, hip, spine, and foot/ankle orthopedic procedures, automatically identifying relevant CPT codes and generating monthly clinical reports. StrideLink serves orthopedic practices, patients in home recovery settings, and clinical researchers. The platform integrates sensor-collected biomechanical data with patient-reported outcomes, producing standardized datasets that document recovery milestones and establish evidence-based recovery timelines. Key features include a patient management portal for healthcare providers, gait asymmetry tracking, StrideLink Performance Score visualization, and automated outcome collection with validated measurement accuracy. The company positions itself as an outcomes-collection and gait-analysis tool accessible across clinical settings and home environments, with dedicated care coordinator support and provider alerts for complications or abnormal recovery patterns.

Strados Labs is a respiratory-focused clinical trial solutions company delivering regulatory-grade endpoint data for pharmaceutical and biotech sponsors through Phase I–IV trials across 34 countries. The company specializes in continuous, ambulatory respiratory monitoring combined with AI-driven analysis and expert human review to capture disease burden between clinic visits. Product offerings include the Air Next Spirometer (FDA-cleared spirometry with FEV₁, FVC, FEV₁/FVC measurement), RESP® Biosensor (FDA 510(k)-cleared wearable capturing high-fidelity cough, lung sounds, vitals, and activity), RESP® Watch (clinical-trial-ready cough and activity monitoring), NObreath® FeNO (point-of-care fractional exhaled nitric oxide for airway inflammation assessment), and eCOA software suite (ePRO, eClinRO, eObsRO for electronic patient-reported and clinician-reported outcomes). Strados recently acquired NuvoAir's clinical trial business to expand its integrated endpoint platform. All devices are FDA 510(k) cleared, CE-marked, and ISO 13485 certified. The company has accumulated 87,000+ hours of respiratory data across 55+ clinical studies and published 70+ peer-reviewed papers in respiratory research journals including ERJ, CHEST, and npj Digital Medicine. Services include study design consultation, site support, device logistics, and GCP-compliant data delivery. The company serves pharma sponsors and contract research organizations seeking single-vendor respiratory endpoint solutions with retained audio, AI detection paired with expert review, and full audit trails for regulatory submission.

Neuroptek is a Canadian-based medical device company specializing in portable, smartphone-integrated eye-tracking and vision testing technology. The company's primary offering is EyeMirage™, a dual-lens optical device paired with a mobile application that enables comprehensive vision assessment and eye movement analysis using standard smartphones. The EyeMirage™ system performs objective measurements including visual acuity, automated visual field testing, color vision assessment, saccadic eye movement analysis, and convergence testing—clinically relevant for concussion diagnosis and neuro-ophthalmologic evaluation. The device accommodates two smartphones simultaneously (one per eye) with custom cases and synchronized dual-screen presentation capability, allowing precise eye-tracking via front-facing camera capture. The companion mobile app (iOS and Android) integrates test administration, personalized health record storage, appointment scheduling, and result documentation. Key clinical applications include sports medicine concussion evaluation, traumatic brain injury assessment, and general neuro-ophthalmologic diagnostics in field, clinic, and home settings. The platform targets team physicians, sports medicine professionals, eye care providers, and institutional settings seeking portable, objective eye-tracking diagnostics. Leadership includes Dr. Behzad Mansouri (CEO, neuro-ophthalmologist and neuroscientist) and Dr. Neda Anssari (CFO, neurologist and concussion specialist), both co-inventors. The company has published extensively in peer-reviewed literature on eye-tracking biomarkers for traumatic brain injury. Note: EyeMirage™ is in investigational status and not yet licensed for commercial sale; pre-order options are announced as forthcoming.

Atomica Technology is an AI-powered digital dentistry platform founded in 2022 that provides an integrated ecosystem of hardware and software solutions for modern dental practices. The company's core offerings include the S300 intraoral scanner for high-accuracy full-arch digital scans in under 60 seconds, complemented by proprietary AI-driven software for treatment planning, implant design, guided surgery, smile design, and CAD/CAM integration. The Atomica Suite connects all digital workflows—from scanning and planning through guides, restorations, and lab handoff—into a single, cloud-based intelligent system. The platform leverages advanced 3D imaging, computer vision, and AI segmentation to deliver precision crown designs and treatment guidance. FDA and CE approved, Atomica targets dental practices worldwide seeking to improve efficiency, treatment accuracy, and patient satisfaction through seamless digital workflows.

Swissmeda AG is a Swiss dental technology company specializing in 3D implant planning software and guided surgery solutions. The company develops and distributes SMOP (Swissmeda Modular Orthopedic Planning), a cloud-based implant planning platform that enables dentists, oral surgeons, and dental technicians to collaboratively plan and execute computer-guided dental implant procedures. SMOP integrates CBCT imaging data with digital surface scans to facilitate precise implant positioning, prosthetic planning, and automated surgical template design. The system generates 3D-printed drilling guides (stents) for accuracy in implant placement and reduces prosthetic complications. Swissmeda operates on a SaaS model with low entry costs, annual subscription fees, and per-case usage charges, eliminating the need for expensive upfront software licenses or scan templates. The platform supports online case sharing and real-time collaboration among surgical teams, reduces intermediate steps in traditional guided implantology workflows, and is used globally across 31 countries. The company maintains a network of certified service partners worldwide for template printing, training, and local support. SMOP has been adopted by academic institutions, specialist practices, and dental laboratories; the platform has completed over 750,000 planning cases and printed over 255,000 templates. The software is available on Windows, Mac, iOS, and Android platforms. Swissmeda holds partnerships with major implant manufacturers and 3D printing service providers.

LymphaTech is a healthcare technology company specializing in validated 3D digital measurement solutions for accurate assessment of human geometry. The platform uses proprietary algorithms to measure volume and circumference of limbs with 99% accuracy compared to water displacement and tape measure methods. LymphaTech serves physical therapists, oncology clinics, compression garment manufacturers, and patients globally. The company offers three integrated solutions: a clinical iPad-based measurement system for frequent in-clinic assessments that reduces measurement time and enables longitudinal tracking; a compression garment fitting module that streamlines sizing and ordering while reducing garment remakes by 33%; and a Bluetooth tape measure with mobile app for at-home self-measurement that connects patients across the care continuum. Validated through external clinical research and adopted by NAPBC-accredited cancer centers and American Cancer Society recommended practices, LymphaTech enables clinicians to focus more on treatment delivery while improving patient engagement and compliance through simplified, standardized measurement workflows.

Syntermed, Inc. is a medical software company specializing in advanced diagnostic imaging analysis tools for nuclear cardiology, brain imaging, and PSMA PET/CT scanning. The company develops FDA-cleared, ISO 13485-certified software solutions that enhance clinical value and diagnostic accuracy across multiple imaging modalities. Primary product lines include the Cardiac Toolbox (eCTB), a comprehensive multi-modality platform for SPECT, PET, calcium scoring, myocardial blood flow, and strain analysis with integrated reporting and remote reading capabilities; NeuroQ 4, brain imaging analysis software for FDG-PET, Amyloid, SPECT, and DatScan imaging; and aPROMISE, a deep learning application for quantitative PSMA PET/CT assessment. Syntermed Live enables remote, cloud-based reading and reporting for nuclear cardiology studies. The company's Smart Scores technology provides automated quantitative segmental analysis with natural language report generation and physician decision support. Products are designed for nuclear medicine departments, cardiology practices, and neuroimaging centers. Syntermed has been the exclusive licensee of the Emory Cardiac Toolbox for over 25 years and recently acquired the intellectual property rights. The company maintains FDA Quality System Records and Pre-Market Notification (510(k)) clearance, along with European Union CE Mark (ISO 13485:2016) certification. All medical devices comply with applicable regulatory frameworks for diagnostic imaging software in the United States and European markets.

CMI Health, Inc. is an FDA and CE-certified manufacturer and distributor of clinical-grade patient monitoring devices and cloud-based software solutions. Founded in 2013 with over 30 years of combined medical device and insurance industry expertise, the company specializes in portable, consumer-friendly vital sign monitors including pulse oximeters and spirometers. CMI Health serves medical professionals in clinics, emergency services, and hospital groups, as well as individual consumers through direct online sales and e-commerce partnerships. The company's integrated platform combines smart medical devices with HIPAA-compliant mobile applications that enable real-time remote patient monitoring, secure data sharing with healthcare providers, and automated health trend tracking. Devices feature advanced sensors, touchscreen displays, USB-C charging, and seamless app connectivity for telemedicine integration. All data is stored on US-based servers with comprehensive security protocols. CMI Health operates US-based customer support and maintains compliance with healthcare data privacy regulations.